Ignite Creation Date:
2024-05-05 @ 11:40 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00106600
Status:
COMPLETED
Last Update Posted:
2023-09-18
First Post:
2005-03-28
Brief Title:
Pixantrone BBR 2778 in Patients With Refractory Acute Myelogenous Leukemia AML
Sponsor:
CTI BioPharma
Organization:
CTI BioPharma
Organization Data
Organization:
CTI BioPharma
Class:
INDUSTRY
Study ID:
PIX109
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
CTI BioPharma
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None